Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects
暂无分享,去创建一个
Koen Van Laere | Guy Bormans | Michel Koole | Karolien Goffin | G. Bormans | K. Van Laere | K. Goffin | P. Rothenberg | R. Hargreaves | M. Koole | I. Grachev | Richard J Hargreaves | I. Guenther | S. S. Bohorquez | I. de Lepeleire | J. Cote | S. S. Sanabria Bohórquez | M. Belanger | H. Burns | Igor D Grachev | Inge De Lepeleire | H Donald Burns | Josee Cote | Paul Rothenberg | Ilonka Guenther | Sandra M Sanabria Bohorquez | Marie J Belanger | D. Burns | I. Lepeleire | M. Bélanger | K. V. Laere
[1] M. Mandelkern,et al. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. , 2005, Nuclear medicine and biology.
[2] J. Marx. Drug development. Drugs inspired by a drug. , 2006, Science.
[3] R. Nicoll,et al. Endocannabinoid Signaling in the Brain , 2002, Science.
[4] F Xavier Pi-Sunyer,et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. , 2006, JAMA.
[5] R. Buchert,et al. [123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Δ9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients , 2004, Biological Psychiatry.
[6] N. Ban. A Brief Introduction of ICRP Publication 62: “Radiological Protection in Biomedical Research” , 1994 .
[7] J. Liow,et al. Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] H. Malcolm Hudson,et al. Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.
[9] V. Dhawan,et al. Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] L. Iversen,et al. Cannabis and the brain. , 2003, Brain : a journal of neurology.
[11] N. Volkow,et al. In vivo imaging of the brain cannabinoid receptor. , 2002, Chemistry and physics of lipids.
[12] J. Marx. Drugs Inspired by a Drug , 2006, Science.
[13] R. Sievert,et al. Book Reviews : Recommendations of the International Commission on Radiological Protection (as amended 1959 and revised 1962). I.C.R.P. Publication 6. 70 pp. PERGAMON PRESS. Oxford, London and New York, 1964. £1 5s. 0d. [TB/54] , 1964 .
[14] L. Petrocellis,et al. The endocannabinoid system and its therapeutic exploitation , 2004, Nature Reviews Drug Discovery.
[15] L. Shaw,et al. Cannabinoids and appetite stimulation , 1994, Pharmacology Biochemistry and Behavior.
[16] Arnaud Peltier,et al. Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters , 1998, European Journal of Nuclear Medicine.
[17] P. V. Ramzaev,et al. Limits for intakes of radionuclides by workers. , 1981, Annals of the ICRP.
[18] H. Burns,et al. Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use. , 2007, Journal of medicinal chemistry.
[19] David G. Cadena,et al. Limits for Intakes of Radionuclides by Workers. ICRP Publication 30, Part 3 , 1983 .
[20] V. Marzo,et al. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol , 2002, British journal of pharmacology.
[21] D. Mankoff,et al. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] Patrick Dupont,et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor , 2007, Proceedings of the National Academy of Sciences.
[23] Michael G Stabin,et al. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] M. Eder,et al. CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.
[25] D. Mankoff,et al. [18F]fluoroestradiol radiation dosimetry in human PET studies. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] Icrp. 1990 Recommendations of the International Commission on Radiological Protection , 1991 .
[27] G. Stamm,et al. [CT-expo--a novel program for dose evaluation in CT]. , 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[28] H. Nagel,et al. CT-Expo - ein neuartiges Programm zur Dosisevaluierung in der CT , 2002 .
[29] M. Gonthier,et al. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes , 2006, Histochemistry and Cell Biology.
[30] K. Laere. In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans , 2007, European Journal of Nuclear Medicine and Molecular Imaging.